Wuhan Pulmonary Hospital

This study compares a 6-month all-oral drug regimen to the standard long treatment for people with rifampin-resistant tuberculosis. About 52 adults in China will take either the short combo (bedaquiline, delamanid, linezolid, levofloxacin) or the usual long course. The goal is to…

This study tests a 6-month treatment for drug-resistant tuberculosis in people with type 2 diabetes. Diabetes can make TB harder to treat, so researchers want to see if a new short-course drug combo (pretomanid, bedaquiline, linezolid, moxifloxacin) works as well and is as safe i…